4JZ1.A | ST14

General Structure Information 4jz1 ST14 crystal structure of matriptase in complex with inhibitor 1.9Å AUTH R.GOSWAMI,S.MUKHERJEE,G.WOHLFAHRT,C.GHADIYARAM,J.NAGARAJ,AUTH 2 B.R.CHANDRA,R.K.SISTLA,L.K.SATYAM,D.S.SAMIULLA,A.MOILANEN,AUTH 3 H.S.SUBRAMANYA,M.RAMACHANDRATITL DISCOVERY OF PYRIDYL BIS(OXY)DIBENZIMIDAMIDE DERIVATIVES ASTITL 2 SELECTIVE MATRIPTASE INHIBITORSREF ACS MED.CHEM.LETT. V. 4 1152 2013REFN ISSN 1948-5875PMID 24900621DOI 10.1021/ML400213V Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants

See Details
3MDJ.C | ERAP1

General Structure Information 3mdj ERAP1 er aminopeptidase, erap1, bound to the zinc aminopeptidase inhibitor, bestatin 2.95Å AUTH T.T.NGUYEN,S.C.CHANG,I.EVNOUCHIDOU,I.A.YORK,C.ZIKOS,AUTH 2 K.L.ROCK,A.L.GOLDBERG,E.STRATIKOS,L.J.STERNTITL STRUCTURAL BASIS FOR ANTIGENIC PEPTIDE PRECURSOR PROCESSINGTITL 2 BY THE ENDOPLASMIC RETICULUM AMINOPEPTIDASE ERAP1.REF NAT.STRUCT.MOL.BIOL. V. 18 604 2011REFN ISSN 1545-9993PMID 21478864DOI 10.1038/NSMB.2021 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants

See Details
3Q2G.B | ADAMTS1

General Structure Information 3q2g ADAMTS1 adamts1 in complex with a novel n-hydroxyformamide inhibitors 2.3Å AUTH C.DE SAVI,A.PAPE,J.G.CUMMING,A.TING,P.D.SMITH,J.N.BURROWS,AUTH 2 M.MILLS,C.DAVIES,S.LAMONT,D.MILNE,C.COOK,P.MOORE,Y.SAWYER,AUTH 3 S.GERHARDTTITL THE DESIGN AND SYNTHESIS OF NOVEL N-HYDROXYFORMAMIDETITL 2 INHIBITORS OF ADAM-TS4 FOR THE TREATMENT OF OSTEOARTHRITISREF BIOORG.MED.CHEM.LETT. V. 21 1376 2011REFN ISSN 0960-894XPMID 21300546DOI 10.1016/J.BMCL.2011.01.036 Variant Set Distributions Mapped Variants

See Details
3ACA.B | NUDT5

General Structure Information 3aca NUDT5 crystal structure of human nudt5 complexed with 8-oxo-dadp and manganese 2.05Å AUTH T.ARIMORI,H.TAMAOKI,T.NAKAMURA,H.KAMIYA,S.IKEMIZU,Y.TAKAGI,AUTH 2 T.ISHIBASHI,H.HARASHIMA,M.SEKIGUCHI,Y.YAMAGATATITL DIVERSE SUBSTRATE RECOGNITION AND HYDROLYSIS MECHANISMS OFTITL 2 HUMAN NUDT5REF NUCLEIC ACIDS RES. V. 39 8972 2011REFN ISSN 0305-1048PMID 21768126DOI 10.1093/NAR/GKR575 Variant Set Distributions Mapped Variants

See Details
3UOA.B | MALT1

General Structure Information 3uoa MALT1 crystal structure of the malt1 paracaspase (p21 form) 1.75Å AUTH J.W.YU,P.D.JEFFREY,J.Y.HA,X.YANG,Y.SHITITL CRYSTAL STRUCTURE OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUETITL 2 LYMPHOMA TRANSLOCATION 1 (MALT1) PARACASPASE REGION.REF PROC.NATL.ACAD.SCI.USA V. 108 21004 2011REFN ISSN 0027-8424PMID 22158899DOI 10.1073/PNAS.1111708108 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
3B1U.A | PADI4

General Structure Information 3b1u PADI4 crystal structure of human peptidylarginine deiminase 4 in complex with o-f-amidine 2.1Å AUTH C.P.CAUSEY,J.E.JONES,J.L.SLACK,D.KAMEI,L.E.JONES JR,AUTH 2 V.SUBRAMANIAN,B.KNUCKLEY,P.EBRAHIMI,A.A.CHUMANEVICH,Y.LUO,AUTH 3 H.HASHIMOTO,M.SATO,L.J.HOFSETH,P.R.THOMPSONTITL THE DEVELOPMENT OFTITL 2 N-ALPHA-(2-CARBOXYL)BENZOYL-N(5)-(2-FLUORO-1-IMINOETHYL)-L-TITL 3 ORNITHINE AMIDE (O-F-AMIDINE) ANDTITL 4 N-ALPHA-(2-CARBOXYL)BENZOYL-N(5)-(2-CHLORO-1-IMINOETHYL)-L-TITL 5 ORNITHINE AMIDE (O-CL-AMIDINE) AS SECOND GENERATION PROTEINTITL 6 ARGININE DEIMINASE (PAD) INHIBITORSREF J.MED.CHEM. V. 54 6919 2011REFN ISSN […]

See Details
3T6J.A | DPP3

General Structure Information 3t6j DPP3 structure of human dppiii in complex with the opioid peptide tynorphin, at 3.0 angstroms 2.98Å AUTH G.A.BEZERRA,E.DOBROVETSKY,R.VIERTLMAYR,A.DONG,A.BINTER,AUTH 2 M.ABRAMIC,P.MACHEROUX,S.DHE-PAGANON,K.GRUBERTITL ENTROPY-DRIVEN BINDING OF OPIOID PEPTIDES INDUCES A LARGETITL 2 DOMAIN MOTION IN HUMAN DIPEPTIDYL PEPTIDASE III.REF PROC.NATL.ACAD.SCI.USA V. 109 6525 2012REFN ISSN 0027-8424PMID 22493238DOI 10.1073/PNAS.1118005109 Variant Set Distributions Ripley’s K Analysis […]

See Details
4H4F.A | CTRC

General Structure Information 4h4f CTRC crystal structure of human chymotrypsin c (ctrc) bound to inhibitor eglin c from hirudo medicinalis 1.9Å AUTH J.BATRA,A.SZABO,T.R.CAULFIELD,A.S.SOARES,M.SAHIN-TOTH,AUTH 2 E.S.RADISKYTITL LONG-RANGE ELECTROSTATIC COMPLEMENTARITY GOVERNS SUBSTRATETITL 2 RECOGNITION BY HUMAN CHYMOTRYPSIN C, A KEY REGULATOR OFTITL 3 DIGESTIVE ENZYME ACTIVATION.REF J.BIOL.CHEM. V. 288 9848 2013REFN ISSN 0021-9258PMID 23430245DOI 10.1074/JBC.M113.457382 Variant Set […]

See Details
4LY1.C | HDAC2

General Structure Information 4ly1 HDAC2 structure of human hdac2 in complex with inhibitor 4-(acetylamino)-n- [2-amino-5-(thiophen-2-yl)phenyl]benzamide 1.57Å AUTH B.E.LAUFFER,R.MINTZER,R.FONG,S.MUKUND,C.TAM,I.ZILBERLEYB,AUTH 2 B.FLICKE,A.RITSCHER,G.FEDOROWICZ,R.VALLERO,D.F.ORTWINE,AUTH 3 J.GUNZNER,Z.MODRUSAN,L.NEUMANN,C.M.KOTH,P.J.LUPARDUS,AUTH 4 J.S.KAMINKER,C.E.HEISE,P.STEINERTITL HISTONE DEACETYLASE (HDAC) INHIBITOR KINETIC RATE CONSTANTSTITL 2 CORRELATE WITH CELLULAR HISTONE ACETYLATION BUT NOTTITL 3 TRANSCRIPTION AND CELL VIABILITY.REF J.BIOL.CHEM. V. 288 26926 2013REFN ISSN 0021-9258PMID 23897821DOI 10.1074/JBC.M113.490706 Variant Set […]

See Details
1WAW.A | CHIT1

General Structure Information 1waw CHIT1 specificity and affinity of natural product cyclopentapeptide inhibitor argadin against human chitinase 1.75Å AUTH F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON,AUTH 2 D.J.ADAMS,K.SHIOMI,S.OMURA,D.M.F.VAN AALTENTITL SPECIFICITY AND AFFINITY OF NATURAL PRODUCTTITL 2 CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS,TITL 3 HUMAN AND BACTERIAL CHITINASESREF CHEM.BIOL. V. 12 65 2005REFN ISSN 1074-5521PMID 15664516DOI 10.1016/J.CHEMBIOL.2004.10.013 Variant Set Distributions Ripley’s K Analysis […]

See Details